Positron Emission Tomography (PET)
Positron emission tomography (PET) is a scanning technique used in conjunction with small amounts of radiolabeled compounds to visualize brain anatomy and function.
PET was the first scanning method to provide information on brain function as well as anatomy. This information includes data on blood flow, oxygen consumption, glucose metabolism, and concentrations of various molecules in brain tissue.
PET has been used to study brain activity in various neurological diseases and disorders, including stroke; epilepsy; Alzheimer's disease, Parkinson's disease, and Huntington's disease; and in some psychiatric disorders, such as schizophrenia, depression, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, and Tourette syndrome. PET studies have helped to identify the brain mechanisms that operate in drug addiction, and to shed light on the mechanisms by which individual drugs work. PET is also proving to be more accurate than other methods in the diagnosis of many types of cancer. In the treatment of cancer, PET can be used to determine more quickly than conventional tests whether a given therapy is working. PET scans also give accurate and detailed information on heart disease, particularly in women, in whom breast tissue can interfere with other types of tests.
A very small amount of a radiolabeled compound is inhaled by or injected into the patient. The injected or inhaled compound accumulates in the tissue to be
A related technique is called single photon emission computed tomography (CT) scan (SPECT). SPECT is similar to PET, but the compounds used contain heavier, longer-lived radioactive atoms that emit high-energy photons, called gamma rays, instead of positrons. SPECT is used for many of the same applications as PET, and is less expensive than PET, but the resulting picture is usually less sharp than a PET image and reveals less information about the brain.
Some of radioactive compounds used for PET or SPECT scanning can persist for a long time in the body. Even though only a small amount is injected each time, the long half-lives of these compounds can limit the number of times a patient can be scanned.
Kevles, Bettyann Holtzmann. Medical Imaging in the Twentieth Century. Rutgers University Press, 1996.
"Brain Imaging and Psychiatry: Part 1." Harvard Mental Health Letter 13 (Jan. 1997): 1.
"Brain Imaging and Psychiatry: Part 2." Harvard Mental Health Letter 13 (Feb. 1997): 1.
Faust, Rita Baron. "Life-Saving Breakthroughs: Innovative Designs and Techniques for Treating Heart Disease." American Health for Women 16 (Sept. 1997): 65.
Powledge, Tabatha M. "Unlocking the Secrets of the Brain: Part 2." BioScience 47 (17 July 1997): 403.
"Studies Argue for Wider Use of PET for Cancer Patients." Cancer Weekly Plus (15 Dec. 1997): 9.
Lisa Christenson, PhD
Electron—One of the small particles that make up an atom. An electron has the same mass and amount of charge as a positron, but the electron has a negative charge.
Gamma ray—A high-energy photon, emitted by radioactive substances.
Half-life—The time required for half of the atoms in a radioactive substance to disintegrate.
Photon—A light particle.
Positron—One of the small particles that make up an atom. A positron has the same mass and amount of charge as an electron, but the positron has a positive charge.